30
Participants
Start Date
March 1, 2024
Primary Completion Date
April 30, 2024
Study Completion Date
April 30, 2024
PECS II block
Treatment group that received the PECS II block using isobaric bupivacaine 0.5% 50 mg
LIA
Treatment group that received the local infiltration anesthesia using isobaric bupivacaine 0.5% 50 mg
RSUP dr. Wahidin Sudirohusodo, Makassar
Hasanuddin University
OTHER